Inhibitory effects of cell-free supernatant of Bifidobacterium bifidum on biofilm formation and virulence gene expression in Group B Streptococcus clinical isolates
Letters in Applied Microbiology · 2025
DOI: 10.1093/lambio/ovaf133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Applied Microbiology, 2025. Verfasst von Uosef Ramezani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Ar.C., Islamic Azad University, Arak 3836119131, Iran. Hauptthemen laut MEDLINE: Biofilms, Streptococcus agalactiae, Streptococcal Infections, Bifidobacterium bifidum. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Group B Streptococcus (GBS) is a major cause of maternal and neonatal infections, complicated by increasing antimicrobial resistance and high virulence. In this study, from 235 vaginal swabs, 45 GBS isolates were identified and screened; 12 representative isolates (strong biofilm producers with the complete virulence gene profile) were selected for downstream analyses. Molecular analysis showed high prevalence of virulence genes (fbsA 95.5%, lmb 91.1%, pavA 88.8%, fbsB 86.6%) and biofilm-related genes (pil-1 88.8%, pil-2a 91.1%, pil-2b 84.4%). Subsequently, a Bifidobacterium bifidum (designated B. bifidum BB-6; GenBank accession number PX474696) isolated from human breast milk was used to prepare a cell-free supernatant (CFS). Gas chromatography–mass spectrometry analysis (GC–MC) of the CFS of B. bifidum identified several bioactive compounds, including acetic acid, propionic acid, and lactic acid. Checkerboard assays indicated synergism between CFS and penicillin/vancomycin, with a fractional inhibitory concentration index (FICI) of ≤ 0.5 in most cases. Sub-minimum inhibitory concentration (sub-MIC) of CFS significantly inhibited biofilm formation (P < 0.01), and quantitative real-time PCR (qRT-PCR) revealed downregulation of virulence (fbsB down −4.40-fold) and biofilm genes (pil-2b down −5.49-fold). These results highlight the therapeutic potential of B. bifidum CFS against GBS, warranting further studies to isolate active compounds and evaluate safety and efficacy in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Ar.C., Islamic Azad University, Arak 3836119131, Iran.
- Department of Microbiology, Sav.C., Islamic Azad University, Saveh 3919715179, Iran.
- Department of Biology, Pa.C., Islamic Azad University, Parand 3761396361, Iran.
Zitieren
APA
Ramezani, U., Amini, K., Jafari, P., & Tafvizi, F. (2025). Inhibitory effects of cell-free supernatant of Bifidobacterium bifidum on biofilm formation and virulence gene expression in Group B Streptococcus clinical isolates. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovaf133
Vancouver
Ramezani U, Amini K, Jafari P, Tafvizi F. Inhibitory effects of cell-free supernatant of Bifidobacterium bifidum on biofilm formation and virulence gene expression in Group B Streptococcus clinical isolates. Letters in Applied Microbiology. 2025. doi:10.1093/lambio/ovaf133
BibTeX
@article{Ramezani2025,
author = {Ramezani, Uosef and Amini, Kumarss and Jafari, Parvaneh and Tafvizi, Farzaneh},
title = {Inhibitory effects of cell-free supernatant of Bifidobacterium bifidum on biofilm formation and virulence gene expression in Group B Streptococcus clinical isolates},
journal = {Letters in Applied Microbiology},
year = {2025},
doi = {10.1093/lambio/ovaf133}
}
EUVIMED